Cancer that forms in tissues of the larynx in the glottis or vocal cords are called as glottic cancer.
This report contains market size and forecasts of Glottic Cancer Treatment in Global, including the following market information:
Global Glottic Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glottic Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glottic Cancer Treatment include Novartis, Eli Lilly, Cipla, Amgen, Biocon, Bristol-Myers Squibb, Merck, Pfizer and Celgene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glottic Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glottic Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glottic Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Surgical Treatment
Drug Treatment
Global Glottic Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Glottic Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Ambulatory Surgical Center
Others
Global Glottic Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Glottic Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glottic Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glottic Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Eli Lilly
Cipla
Amgen
Biocon
Bristol-Myers Squibb
Merck
Pfizer
Celgene
Roche
Teva